MR. DAN CRIPPEN

MR. DAN CRIPPEN filed a registration for AMGEN on May 7, 2025.

Lobbying for AMGEN · Manufacture Pharmaceuticals

Filing · LD-1 registration Registration

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted May 7, 2025

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

District of Columbia

Lobbying activity 1

pharmacy pricing, R&D, chronic disease

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.